I’m probably a little too optimistic about cancer at this point, but everything the company and RP has shown is playing out. Now we just need the clinical results to prove this.

I think the quote you are referring to is:
“They also announced their intentions to proceed with eight phase 2 clinical trials in cancer after they complete their preclinical studies which is a feat that only eight $100 billion dollar drug companies have ever accomplished.”

This is from the emerging growth Feuerstein counter article here:

https://emerginggrowth.com/bio-path-nasdaq-bp...-analysis/

I tried to confirm this quote from the same article with no satisfying answer yet.

“This point needs to resonate, because they might be mice, but 90% of mouse efficacy studies predict human results.”